Lantheus Holdings LNTH
NASDAQ LNTH
$101.77 +0.18 (+0.18%)
As of: Nov 16, 2026 · 1:30 PM EST

Lantheus Holdings (LNTH) Current Deferred Revenue (2023 - 2026)

Updated

Lantheus Holdings' Current Deferred Revenue was $9.37 million in Q3 2026, down 0.9% from the prior quarter.

Analysis

Lantheus Holdings (LNTH) Current Deferred Revenue (2023 - 2026) Analysis & Trends

At the end of FY2025, Current Deferred Revenue at Lantheus Holdings came in at $6.98 million, up 382.7% from FY2024.

  • In earlier years, Current Deferred Revenue was $1.45 million in FY2024 (-2.8%) and $1.49 million in FY2023.
  • Quarterly Current Deferred Revenue has moved between $1.45 million (Q4 2024) and $9.45 million (Q2 2026) over five years.
  • Per Business Quant data, LNTH's Current Deferred Revenue in the three quarters before Q3 2026 was $9.45 million (Q2 2026), $6.6 million (Q1 2026) and $6.98 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.22 Bn 233.73 Bn 5.13 Bn
2 Abbott Laboratories 187.81 Bn 161.67 Bn 7.39 Bn
3 Danaher 162.97 Bn 142.63 Bn 3.84 Bn
4 Intuitive Surgical 153.97 Bn 134.25 Bn 2.08 Bn
5 Medtronic 132.11 Bn 97.62 Bn 6.34 Bn
6 Stryker 118.83 Bn 105.01 Bn 4.25 Bn
7 Boston Scientific 63.58 Bn 59.01 Bn 3.43 Bn
8 Edwards Lifesciences 61.52 Bn 44.73 Bn 1.35 Bn
9 Agilent Technologies 48.76 Bn 41.65 Bn 1.04 Bn
10 Lantheus Holdings 6.65 Bn 4.51 Bn 243.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 9.37 Mn
Jun 30, 2026 9.45 Mn
Mar 31, 2026 6.60 Mn
Dec 31, 2025 6.98 Mn
Dec 31, 2024 1.45 Mn
Dec 31, 2023 1.49 Mn
API Access

Lantheus Holdings Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=LNTH&period=max&api_key=YOUR_API_KEY